HFD-reversal prompted rapid weight loss (Figure 1(a)), normalization of fat pads (Supplementary Figure 1A), glucose/insulin concentrations (Supplementary Figure 1B and C) and reduced hepatic steatosis (Figure 1(b) and Supplementary Figure 2) assessed by NAS steatosis scoring. The gene discussed is INS; the disease is steatosis.